Address
  • Viikinkaari 5E, PO Box 56, Biocenter 2

    00790 Helsinki

    Finland

Find us here

Organization profile

Organisation Profile

Our research team makes the unique bridge between medical engineering, pharmaceutical nanotechnology and biomedical research by combining unique techniques, such as microfluidic glass technology, to help to build innovative nanomedicines/nanovectors and multidrug loading. To design and test the functionality and efficacy of these nanomedicines, we use state-of-the-art nanotheranostic technologies for personalized medicine, which allow the precisely engineering of materials at nanoscale to develop novel therapeutic formulations, including industrial scale-up validation, batch-to-batch reproducibility, and controllability of the nanomaterials’ physicochemical properties for translation into the clinic.

International and National Collaboration

Publications and projects within past five years.